Unhealthy diet and sedentary lifestyle as a cause in the development of Diabetes Mellitus and its treatment with some ayurvedic drugs

An Epidemiological Study to identify Santarpaá¹?a Hetu and to assess the Quality of Life in Patients of Madhumeha (Diabetes Mellitus) and Therapeutic Trial to Evaluate the Efficacy of NyagrodhÄ?di Vaá¹Ä« and Mehamudgara Vaá¹Ä« - ESISHAQOLMTNM

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/12/010837

Enrollment

120

Registered

2017-12-11

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Mehamudgara Vaá¹Ä«: Mehamudgara Vaá¹Ä« 1 gm /day in 2 divided doses (2 Vaá¹Ä« BD, each Vaá¹Ä« of 250 mg) with Luke warm water for 6 weeks. Control Intervention1: NyagrodhÄ?di Vaá¹Ä

Eligibility

Inclusion criteria

Inclusion criteria: Patients of type-2 diabetes fulfilling the criteria of American Diabetes Association (ADA) for Diabetes Mellitus. Patients of age group 30 years â?? 70 years of either gender. Patients who shows clinical signs and symptoms of Madhumeha (type- 2 DM).

Exclusion criteria

Exclusion criteria: Patient of IDDM (type-1 D.M.) Complicated cases of Diabetes Mellitus. Type-2 Diabetes patient on insulin therapy. Patients with Gestational Diabetes Mellitus and lactating mother etc. Patients with Fasting blood sugar more than 200 mg/dl and post prandial blood sugar more than 300 mg/dl. Diabetic patients with severe complications like cardiovascular diseases, Nephropathy, Retinopathy, Diabetic foot etc. Diabetes due to endocrinopathies e.g. Phaeochromocytoma, Acromegaly, Cushingâ??s syndrome, Hyperthyroidism etc. Patients with genetic syndromes associated with D.M. like Downâ??s syndrome,Klinefelterâ??s syndrome, Turnerâ??s syndrome.

Design outcomes

Primary

Measure	Time frame
Developed low cost management in Madhumeha (Diabetes) for symptomatic relief in Madhumehi (Diabetic) patients.Timepoint: 6 weeks	—

Secondary

Measure	Time frame
Devoloped awareness about Santarpana Hetu(Unhealthy diet and Sedentary lifestyle) in Diabetic patients.Timepoint: 6 weeks	—

Countries

India

Contacts

Public ContactDr Talekar Manisha Tatobaji

National Institute of Ayurveda, Jaipur

drbks6@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026